Merck seeks FDA approval for subcutaneous pembrolizumab

Subcutaneous pembrolizumab administered every six weeks with a median injection time of two minutes, in combination with chemotherapy, shows consistent results across reported efficacy and safety endpoints compared to IV KEYTRUDA in combination with chemotherapy

Curium completes acquisition of Monrol

Positions Curium as leading manufacturer of Lu-177 isotope

Merck and Zebra Technologies collaborate to create safety and traceability solutions

Collaboration combines data, identity capture and Web 3.0 crypto technologies to enhance product safety, traceability, and data integrity for AI systems

Mila Beaute raises $2.16 million in pre-series A round led by Rukam Capital

The freshly infused capital will primarily be deployed towards expansion and research & development

Glenmark launches nutrition program to fight malnutrition in Philippines

This program, titled "Food Supplementation and Capacity Building Support for Improved Nutrition in Malinao, Aklan," aligns with the country’s national health

AstraZeneca to invest $2.5 billion in new global strategic R&D centre in China

Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai

Entero launches ‘HealthEdge’ programme to empower Retail Chemists

Anupriya Patel inaugurates India Innovation Summit – Pioneering Solutions to End TB

TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023

CKD cases surge to 16.38% in Indians aged 15+

Experts urge early detection & better access to care

Sigachi Industries signs MoU with INS Kalinga to promote healthy living

The programme will take place on the 2nd Sunday of every month